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As a research scholar, I was overjoyed by the rich and comprehensive
Tables of Common Law Jurisdictional Cases3" and Civil Law Jurisdic-
tions.3' Comparative analysis is thus expedited greatly by these tables as
well as an equally superb subject index. 32 A book without a good index and
set of comparative cases and appendices 33 is only half a book for the consci-
entious scholar and even the casual reader.
In his Preface, the author states the simple goal of his book as being an
opportunity "to furnish instances of cross-cultural enrichment in efforts to
adapt yesterday's law to the requirements of today and tomorrow through
both international and inter-disciplinary co-operation." ' 34 The key to achiev-
ing this goal is, as observed, through informed decisionmaking.35 Without
question, this goal is achieved admirably, with the treatise itself serving as a
blueprint of education and hoped-for action in preventing medical
malpractice.
AIDS. Public Health and Legal Dimensions. By D. C.
Jayasuriya. Dordrecht: Martinus Nijhoff. 1988. 145 Pp.
$57.00.
Reviewed by Kathleen Sazama, M.D. *
Among the abundant literature arising from what has been arguably the
worst pandemic in history, this small volume contributes little. The rapidity
of crisis events renders most information outdated before it reaches publica-
tion. Even so, this book creates a hodge-podge of occasionally inaccurate
data concerning some of the public health and legal measures that were in
place by mid-1987, data that has been sporadically applied out-of-context or
in a surprisingly disjointed manner. Unfortunately, the author overlooked
30. D. GIESEN, supra note 9, at 756-810.
31. Id. at 810-31.
32. Id. at 847-923.
33. Id. at 727-55. The Appendices on the Resolutions of the German Legal Professions
Congress on Artificial Technologies and The Council of Europe's Recommendations on Use of
Human Embryos and Foetuses are especially useful.
34. D. GIESEN, supra note 9, at XVII.
35. Kilbrandon, supra note 4, at VI-VII.
* Consultant, Ober, Kaler, Grimes & Shriver, Baltimore, MD. B.S., 1962, University of
Nebraska; M.S., 1969, The American University; M.D., 1976, Georgetown University College
of Medicine; J.D., 1990, The Catholic University of America.
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the available rich resources in both medical-scientific' and legal2 literature
that could have made this work a more significant addition to the AIDS
dialogue.
Jayasuriya has compiled, through the use of large type, the equivalent of
an average law review commentary. Each of the seven chapters is but a
synopsis of the vast knowledge amassed since AIDS was first recognized in
1981, and, unfortunately, errors abound. In addition, fully one-half of the
book is devoted to appendices which contain most of the useful information
compiled through mid-1987. Their inclusion partially redeems an otherwise
disappointing publication.
The seven chapters, comprising the first sixty-nine pages, begin with an
overview entitled "Some Dimensions of the AIDS Pandemic" and conclude
with "An A to Z Catalogue of Intervention Measures." The intervening five
chapters, "A Comparative Survey of AIDS Legislation," "Blood and Blood
Products," "Screening and International Travel," "Condoms and the Pre-
vention of AIDS," and "Drug Abusers and the Use of Injections," display
the seemingly random order in which pertinent topics of the AIDS epidemic
are discussed. Not readily apparent is the recurring theme of disorganiza-
tion in the contents of each chapter.
Despite its promise, no central cohesive theme arises from the title and
weaves throughout the chapters. If the author intended the book to be a
litany of various public health and legal interest topics created by the AIDS
epidemic, accompanied by a random discussion of international responses to
it, then the title is clearly misleading. Far from "offering a new point of view
or perspective," this book is a conglomerate of misstatements and inaccura-
cies presented in a manner that defies comprehension. This confusion is par-
ticularly inexcusable in light of timely summary articles3 available which
offered a coherent and logical framework on which to construct interesting
international comparisons.
The initial pages of Chapter One offer some examples of the disturbing,
careless use of scientific and technical information apparent in this book.
Beginning with paragraph one, the characterization of most AIDS patients
as "from industrialized countries, though new cases have been detected in
1. AIDS: ETIOLOGY, DIAGNOSIS, TREATMENT AND PREVENTION (V. DeVita, S.
Heilman & S. Rosenberg eds. 1986)[hereinafter AIDs ETIOLOGY].
2. See, e.g., Howe, Ethical Problems in Treating Military Patients with Human Immu-
nodeficiency Virus Diseases, 3 J. CONTEMP. HEALTH L. & POL'Y 111 (1987); Duncan, Public
Policy and the AIDS Epidemic, 2 J. CONTEMP. HEALTH L. & POL'Y 169 (1986); Comment,
Protecting the Public from AIDS: A New Challenge to Traditional Forms of Epidemic Control, 2
J. CONTEMP. HEALTH L. & POL'Y 191 (1986) [hereinafter Comment].
3. Matthews & Neslund, The Initial Impact of AIDS on Public Health Law in the United
States-1986, 257 J. A.M.A. 344 (1987).
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other countries, especially the African continent ' 4 inaccurately reflects the
situation. Although the U.S. alone presently accounts for 57% of all re-
ported AIDS cases,5 the following more accurately depicts the geographic
concentration of the disease: (1) at the time the first U.S. cases were diag-
nosed, the disease was also known to be present among Haitians; 6 (2) AIDS
probably originated in Africa where it is endemic in some populations, sug-
gested in part by serologic testing of stored blood samples;7 (3) the per cap-
ita rate of HIV infection was nearly as high in 1987 in the Caribbean (53.9/
reported cases per one million in population) as in North America (67.2/
reported cases per one million in population);8 and (4) as has been true for
the past several years and again demonstrated in statistics of the World
Health Organization (WHO), the ratio of reported cases is rising in other
countries much faster than in the U.S.9
Appendix A, AIDS Cases Reported to WHO (as of June 3, 1987), refer-
enced at the end of paragraph one, disappointingly provides only a single
data point by country reporting. The table would be significantly more in-
teresting and useful if it included for each listed country such additional
information as the date of the first reported AIDS case, several data points in
chronological sequence, a listing of the population as of the nearest census
date, and a percentage calculation of the relative risk of AIDS in the popula-
tion on the date reported, or other similar data.' ° The data actually
presented is available in more complete and current form, from the World
Health Organization or other timely reports.'1
In the second paragraph, as well as throughout the book, the author mis-
4. D. JAYASURIYA, AIDS: PUBLIC HEALTH AND LEGAL DIMENSIONS 1 (1988).
5. The World Health Organization on September 1, 1989, stated that the number of
AIDS cases reported had reached 177,965 since the agency began keeping records in 1979.
The number of cases in the United States reached an unprecedented 100,885, making it the
largest reporter of cases. 4 AIDS Pol'y & L. (BNA) at 9 (Sept. 6, 1989).
6. Curran, Acquired Immune Deficiency Syndrome (AIDS): Surveillance and Epidemio-
logic Obserations in the United States, in THE ACQUIRED IMMUNE DEFICIENCY SYNDROME
AND INFECTIONS OF HOMOSEXUAL MEN 208 (P. Ma & D. Armstrong eds. 1984).
7. Essex, Origins of AIDS, in AIDS ETIOLOGY, supra note 1, at 5.
8. PAN AMERICAN HEALTH ORGANIZATION, AIDS: PROFILE OF AN EPIDEMIC 214
(Table 2) [hereinafter AIDS PROFILE].
9. US., African Nations Lead in Total AIDS Cases Reported, 4 AIDS Pol'y & L. (BNA)
at 10 (Aug. 9, 1989). The number of cases of AIDS reported through July 31, 1989, was
172,143, of which the United States reported 98,255 cases, Brazil reported 6,857 cases and
Uganda reported 6,772 cases (the three most affected countries). Id.
10. See, e.g., First 100,000 Cases of Acquired Immunodeficiency Syndrome-United States,
262 J. A.M.A. 1453 (1989); AIDS PROFILE, supra note 8, at 220.
11. See, e.g., UNITED STATES DEP'T OF HEALTH AND HUM. SERV., CENTERS FOR DIS-
EASE CONTROL, HIV/AIDS SURVEILLANCE 5 (Table 1) (May 1989).
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takenly uses the term "gestational" 2 rather than "incubation" 3 or "la-
tent" 1 4 period of HIV. This error is inexplicable in view of the sizable
scientific literature available to the author in which the term "latency" is
appropriately used to describe the delay between acquiring the virus and the
appearance of detectable indicators of its presence."
In the same paragraph, Jayasuriya identifies "target groups of potential
victims includ[ing] homosexual and bisexual men and their partners and in-
fants, haemophiliacs, intravenous drug abusers, and recipients of blood
transfusions." 6 This list of potential "target victims" inappropriately ex-
cludes the sexual partners of the last three categories, who were known to be
part of the largely unidentified pool of possibly infected persons in 1987. It
also implies that the listed persons are peculiarly susceptible to infection. In
fact, it is these persons' activities or state of being that place them at risk of
disease, not any special individual predisposition to susceptibility. The sex-
ual partner of a sexual partner of an asymptomatic HIV-infected person may
unwittingly become infected because he or she is unaware that his or her
sexual partner is also sexually involved with the HIV-infected person. 7 Un-
12. "Gestation" is defined as:
1. The act of carrying young in the womb from conception to delivery; pregnancy;
2. the development of a plan in the mind;
3. exercise in which one is borne or carried [RARE].
WEBSTER'S NEW TWENTIETH CENTURY DICTIONARY 760 (2d ed. 1979).
13. "Incubation" is defined as: "2. the phase in the development of a disease between the
infection and the first appearance of symptoms." Id. at 927.
14. Shaw, Wong-Staal & Gallo, Etiology of AIDS: Virology, Molecular Biology, and Evolu-
tion of Human Immunodeficiency Viruses, in AIDS ETIOLOGY, supra note 1, at 17.
15. See, e.g., Landesman, Ginzburg & Weiss, The AIDS Epidemic, 312 NEW ENG. J.
MED. 521 (1985); Blattner, Biggar, Weiss, Melbye & Goedert, Epidemiology of Human T-
Lymphotropic Virus Type III and the Risk of Acquired Immunodeficiency Syndrome, 103 AN-
NALS INTERNAL MED. 665 (1985); Jaffee, Feorino, Darrow, O'Malley, Getchell, Warfield,
Jones, Echenberg, Francis & Curran, Persistent Infection with Human T-Lymphotropic Virus
Type III/Lymphadenopathy-Associated Virus in Apparently Healthy Homosexual Men, 102
ANNALS INTERNAL MED. 627 (1985); Levy, Hoffman, Kramer, Landis, Shimabukuro &
Oshiro, Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS, 225
SCIENCE 840, 840-41 (1984); Popovi, Sarngadharan, Read & Gallo, Detection, Isolation and
Continuous Production of Cytopathic Retroviruses (HTL V-Ill) from Patients with AIDS and
Pre'AIDS, 224 SCIENCE 497, 497-500 (1984); Barre-Sinoussi, Chermann, Rey, Nugeyre,
Chamaret, Gruest, Dauguet, Axler-Blin, Vezinet-Brun, Rouzioux, Rozenbaum & Montagnier,
Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Defi-
ciency Syndrome (AIDS), 220 SCIENCE 868, 868-71 (1983).
16. D. JAYASURIYA, supra note 4, at 2.
17. See, e.g., Duncan, supra note 2, at 170 n.1 (quoting Dr. Donald R. Hopkins of the
Center for Disease Control who stated that it has become increasingly obvious "that AIDS is
being spread largely by people who, though infected, have not become ill." N.Y. Times, Mar.
14, 1986, at 9, col. 1.).
1990]
444 Journal of Contemporary Health Law and Policy [Vol. 6:437
protected casual sexual contact is a far more common phenomenon than is
publicly acknowledged in most cultures.
The author continues by expressing a surprisingly naive attitude that "a
sudden breakthrough . . . is not unusual in the domain of medical sci-
ences."" This statement is a wishful expression by a non-scientist that ig-
nores the reality of long years of unrewarded effort frequently preceding
each "sudden breakthrough." In nearly every authoritative paper or article
written about this epidemic, the author acknowledges as an anomaly the
astonishingly, rapid rate with which scientific knowledge about this virus has
been gained.' 9 June E. Osborn, M.D., Dean of the School of Public Health
of the University of Michigan, one of the world's foremost authorities on the
AIDS epidemic and the newly elected chairperson of the U.S. National
Commission on AIDS,20 succinctly summarizes the prevailing scientific view
that "[a]s the first cases of AIDS were being recognized, the sciences of vi-
rology, immunology, and molecular biology were reaching advanced levels
of sophistication. If the epidemic had begun 20 years earlier, it might have
remained an enigma much longer."21 One need only consider the protracted
search for and persistent failure to find a "cancer cure" to comprehend how
rarely "scientific breakthroughs" occur.
Rounding out the uncertainty introduced in his opening remarks, the au-
thor then asserts without support that "[1]egislation has a fairly long and
perhaps singularly impressive record as an important instrument of change
in the domain of public health."22 The only hint of support for this state-
ment is found where, after making additional unsubstantiated statements
about the importance of legislation for public health, the author directs the
reader to Chapter Two and Annex B.
Neither Chapter Two nor Annex B provides the anticipated foundation.
Although Chapter Two lists various legislative approaches used internation-
ally, no direct reference to specific law as an important instrument of change
is ever made. In fact, nowhere does the author provide explicit direction to
legislation. Rather, he provides only a listing of legislative acts by country in
Annex E. Even in this listing, however, there is only a chronological sum-
mary of events without further analysis of the content or discussion of the
purpose to which the legislation was directed. The reader is left to unearth
18. D. JAYASURIYA, supra note 4, at 2.
19. Shaw, Wong-Staal & Gallo, supra note 14, at 13.
20. New AIDS Commission Convenes, Elects June Osborn as Chair, 4 AIDS Pol'y & L.
(BNA) at 2 (Aug. 9, 1989).
21. Osborn, The Aids Epidemic: Discovery of a New Disease, in AIDS AND THE LAW 21
(H. Dalton, S. Burris and the Yale AIDS Law Project eds. 1987).
22. D. JAYASURIYA, supra note 4, at 2.
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individually how the new amendments affect the existing public health laws
of each country.
The reference to Annex B is likewise unsatisfactory in that it provides a
comparison of only "Two National Case Studies of Legislative Policies,"
Austria and the United States. Furthermore, the term "comparison" is mis-
applied, because the discussion first lists only activities undertaken by Aus-
tria, then addresses only state (not federal) activities in the U.S., using an
arbitrarily devised alphabetical listing of activities beginning with "Blood
Supply" and ending with "Task Forces."
These flaws are a mere sampling of the book's many shortcomings. The
fact that they occur in the opening paragraphs calls into question the relia-
bility of the author's presentation and interpretation of other information
selectively included. When the author asks the reader to believe that:




-those exposed to HIV;




the reader's apprehension concerning the author's lack of knowledge of epi-
demiology's basic principles is well-founded. In fact, in this epidemic as in
so many others in the past, there are two foci of public health measures: to
identify and help those already infected (whether or not overtly ill) and to
prevent the spread of the disease to those who are not.2 4
The special dilemmas for both public health and legal intervention posed
by the AIDS epidemic are due in large measure to two facts: 1) at the time
of its appearance, AIDS was primarily a sexually transmitted disease; and 2)
it principally infected persons whose sexual activities were considered exper-
imental or non-traditional.25 The less frequent transmission by blood-con-
taining needles, either from illicit drug use or transfusion of blood products,
also poses special concerns. These concerns are magnified when the ad-
dicted persons sharing infected needles are women whose offspring suffer the
harm of such practices26 and when eliminating unsafe blood is beyond the
23. Id. at 4.
24. Comment, supra note 2, at 201.
25. Glasel, High-Risk Sexual Practices in the Transmission of AIDS, in AIDS ETIOLOGY,
supra note 1, at 355-57.
26. Specter, Third World Nations say They're Losing AIDS War, Wash. Post, June 13,
1989, at Z6 (Health), col. 2. In Kampala, Uganda, 20 percent of all infant deaths are now
caused by HIV infection. Id. at Z7, col. I.
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economic resources of third world countries.27
Chapter Three, "Blood and Blood Products" provides a cursory reference
to the recognition of the United States in 1984 that AIDS was transmissible
in blood. It then mentions only France's action to compel blood screening.28
By failing to state that when the United States licensed the first HIV screen-
ing test in March 1985, it not only recommended that all blood collected (for
whatever purpose) be screened but also provided the first means by which
reliable blood screening was possible, the author precludes cognition of how
singular that contribution was to beginning to control the spread of disease.
The majority of this author's discussion of blood products occurs in Chap-
ter Two, beginning with a misstatement regarding the timing of the United
States' requirement for HIV testing of blood products.29 He provides no
references for statements regarding requirements imposed by the govern-
ments of Spain, Sweden, the United Kingdom, Belgium, France, Austria, the
Federal Republic of Germany, Switzerland, Australia, Canada, and Hun-
gary, as well as the Council of Europe. In addition, the author confuses
existing regulations by the U.S. Food and Drug Administration (FDA) with
new legislation enacted in other countries. The FDA has been responsible
for protection of the American blood supply since the amendment of the
Public Health Service Act in 1972,30 while the specific procedures to be fol-
lowed to accomplish this protection are updated frequently. 3
As part of the blood products discussion in Chapter Two, the author mis-
takenly claims that in the state of Tennessee "any person who contracts
AIDS from any contaminated blood or blood product will have a cause of
action for damages (including medical expenses) against any facility which
supplied untested blood or a blood product derived therefrom." 32 No cita-
tion is given. Because 48 of the 50 states33 (including Tennessee) have a
"blood shield" statute protecting blood suppliers from liability for transmit-
ting disease, and because no supplier has been held liable for not testing
before testing was available,3 4 the author's statement may not be completely
27. Id. It can cost up to $50 just to eliminate one unit of infected blood in most African
countries. Yet places like Zaire and Uganda have less than one dollar to spend each year per
person for all their health needs. In the United States, per capita health care spending is
almost six hundred dollars. Id.
28. D. JAYASURIYA, supra note 4, at 38.
29. Id. at 14.
30. 42 U.S.C. § 201 (1982).
31. 21 C.F.R. §§ 600-699 (1989).
32. D. JAYASURIYA, supra note 4, at 23.
33. The two states without "blood-shield" statutes are New Jersey and Vermont. Sazama,
Legal and Regulatory problems Facing Blood Suppliers, 6 HEALTHSPAN 8, 14 n.6 (Sept. 1989).
34. See, e.g., Sazama, Legal and Regulatory Problems Facing Blood Suppliers, 6 HEALTH-
SPAN 8, 9 (Sept. 1989).
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accurate. Additionally, blood donor disclaimer attestations in countries
outside the United States have been generally patterned after the FDA
recommendations.
Chapter Four, discussing screening and international travel, opens with a
quotation about sex with a prostitute (a quote that strikes this reviewer as
being more attuned to the topic of the subsequent chapter, namely, condoms
and the prevention of AIDS or perhaps to a consolidation of these two chap-
ters). Generally, the policy considerations underlying requirements for
screening and/or testing for selected contagious diseases have been directed
toward persons who propose to become resident for some period of time,
e.g., foreign students or aliens seeking work, as well as to persons who regu-
larly engage in illicit behavior such as drug abuse or prostitution. As
quoted by Jayasuriya, the World Health Organization considered the ques-
tion of screening and international travel in March 1987 and concluded that
HIV screening would serve no useful purpose.35 This entire chapter can be
replaced with that single sentence.
The cursory discussion in Chapter Five appropriately identifies, without
reference, the scientific concerns about reliability and the economic reality of
condom availability. This chapter provides no information regarding any
legal aspects regarding condom use, not even discussing which countries
prohibit such interventions and whether new legislation has been proposed
or enacted to encourage wider use. The few references included in this
chapter address mostly the American experience and provide no insight re-
garding pending or actual activities for implementing an international strat-
egy of public health or legal impetus to encourage condom use. Discussing
condoms without mentioning the accompanying controversy over compre-
hensive sex educational programs 36 seems singularly abstruse.
The treatment of drug abusers and the use of injections addressed in
Chapter Six suffers from a similar lack of both data and analysis, and a dis-
cussion of the need for education as the foregoing chapter. Unsupported
statements such as "[a] significantly large number of persons with AIDS or
HIV in the United States and Europe are parenteral drug abusers ' 37 and
"[m]any more countries are affected by drug abuse today than some five or
ten years ago" 38 leave the reader bereft of a basis to accept them as true.
Only two examples of proposals for control of drug dependence, one Ameri-
can and one Italian, are given, with no reference for the Italian action. Fur-
35. D. JAYASURIYA, supra note 4, at 48.
36. Voelker, No Uniform Policy Among States on HIV/AIDS Education, AM. MED.
NEWS, Sept. 15, 1989, at 3.
37. D. JAYASURIYA, supra note 4, at 56.
38. Id. at 57.
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ther, this reviewer would be satisfied with just one example of a country,
aside from the United States, in which "AIDS-related activities and drug
abuse control work tend to be done by different agencies at the national
level." 39
Chapter Seven, the concluding chapter, consists of "a representative sam-
ple of various measures ... which have been discussed during the past few
years."'  In fact, this chapter substitutes for an index, containing nothing
more than an arbitrary alphabetical listing of the author's ideas regarding
the subject matter, absent the necessary page references. Jayasuriya offers
up this potpourri, disclaiming any responsibility, while advising that:
this catalogue serves as a convenient check-list for countries to as-
sess the validity of any proposal in relation to factors such as
- medical, scientific and technological readiness and
validity;
- political expediency;
- economic feasibility; and
- legal, ethical, cultural and social acceptability.41
The omissions are glaring: no reference to access to health care or to the
legal system, public health laws, drug development, compulsory screening,
anal-receptive sex as high risk activity, high-risk activity for infection,
hemophiliacs and spouses at special risk, special programs for infants born
infected with HIV, or anonymous testing. The relevance of this chapter is
simply not apparent, other than as a substitute for a partial index.
Rounding out the remaining 78 pages are Appendices A through E. Ap-
pendices A, B and E have been discussed in the preceding paragraphs. Ap-
pendices C and D contain "Guidelines and Recommendations of the U.S.
Centers for Disease Control and the World Health Organization," rear-
ranged to suit the author's approach, and "WHO/CDC Case Definition for
AIDS," valuable resources only if one has no access to other publications in
which both or either appear.
Not included in any appendix, but of greater value to the reader, is a dis-
cussion of the WHO global strategy for AIDS control. The strategy was first
announced in November 1986, with establishment of the WHO Special Pro-
gram on AIDS (SPA) in February 1987, and has recently been included in
the newest edition of a premier medical reference on AIDS (to which the
reader is commended).42 The plan has three major objectives: (1) To prevent
39. Id. at 60.
40. Id. at 62.
41. Id.
42. Zagury & Lurhuma, AIDS Control in Africa, in AIDS ETIOLOGY, supra note 1, at
431-45.
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HIV transmission; (2) To take care of HIV-infected persons (to reduce mor-
bidity and mortality associated with HIV-infections; the care of HIV-in-
fected persons is not limited to medical management or to AIDS or AIDS-
Related Complex (ARC) patients; combatting discrimination against HIV-
infected persons is as vital to the global strategy as provision of medical
care); and (3) To unify national and international AIDS control efforts.43 In
a recent symposium on AIDS," the special needs of healthcare workers in-
ternationally was addressed.45
Many well-written articles46 and books47 about both the public health as-
pects and legal issues surrounding the AIDS epidemic continue to appear.
Perhaps a scholarly analysis of international efforts to control AIDS by pub-
lic health and legislative action will be forthcoming, but this book misses the
mark.
FINAL CHOICES: AUTONOMY IN HEALTH CARE DECISIONS.
George P. Smith, II. Illinois: Charles C. Thomas. 1989. 198
Pp. $37.75.
Reviewed by Randy Howe, M.D. *
The core argument of this book is that competent individuals should be
permitted to take their own life so long as their decision is rational. This
43. Id. at 439-43.
44. Brandt, Health Care Workers and AIDS, 48 MD. L. REV. 1 (1989).
45. Fluss & Zeegers, AIDS, HIV and Health Care Workers: Some International Legisla-
tive Perspectives, 48 MD. L. REV. 77 (1989).
46. See, e.g., Acquired Immunodeficiency Syndrome Associated With Intravenous-Drug
Use-United States, 1988, 261 J. A.M.A. 2314 (1989); Dalakas, Wichman, & Sever, AIDS
and the Nervous System, 261 J. A.M.A. 2396 (1989); Turnock & Kelly, Mandatory Premarital
Testing for Human Immunodeficiency Virus, 261 J. A.M.A. 3415 (1989); Joseph, Premarital
AIDS Testing: Public Policy Abandoned at the Altar, 261 J. A.M.A. 3456 (1989); Quinn, AIDS
in the Americas: An Emerging Public Health Crisis, 320 NEW ENG. J. MED. 1005 (1989);
Howe, supra note 2; Matthews, supra note 3; Duncan, supra note 2; Comment, supra note 2.
47. See, e.g., R. BAYER, PRIVATE AcTs, SOCIAL CONSEQUENCES: AIDS AND THE POLI-
TICS OF PUBLIC HEALTH (1989); AIDS PROFILE, supra note 8; R. SHILTS, AND THE BAND
PLAYED ON (1987); AIDS AND THE LAW (H. Dalton, S. Burris and the Yale AIDS Law
Project eds. 1987); AMERICAN MEDICAL ASSOCIATION, AIDS: INFORMATION ON AIDS FOR
THE PRACTICING PHYSICIAN (1987); AIDS ETIOLOGY, supra note 1.
* Associate Professor of Psychiatry, Director of Programs in Ethics, Uniformed Serv-
ices University of the Health Sciences; Editor, Journal of Clinical Ethics. B.A., Yale Univer-
sity; M.D., Columbia University; J.D., Catholic University of America.
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